nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR5A—autistic disorder	0.334	0.447	CbGaD
Loxapine—HTR3A—autistic disorder	0.0937	0.125	CbGaD
Loxapine—HTR1D—autistic disorder	0.0926	0.124	CbGaD
Loxapine—HTR1B—autistic disorder	0.055	0.0736	CbGaD
Loxapine—DRD3—autistic disorder	0.0533	0.0715	CbGaD
Loxapine—DRD1—autistic disorder	0.0524	0.0701	CbGaD
Loxapine—SLC6A4—autistic disorder	0.0371	0.0497	CbGaD
Loxapine—HTR2A—autistic disorder	0.0285	0.0382	CbGaD
Loxapine—DRD3—telencephalic ventricle—autistic disorder	0.00292	0.0324	CbGeAlD
Loxapine—HTR5A—forebrain—autistic disorder	0.00219	0.0243	CbGeAlD
Loxapine—DRD1—telencephalic ventricle—autistic disorder	0.00209	0.0232	CbGeAlD
Loxapine—HTR1B—telencephalic ventricle—autistic disorder	0.00169	0.0188	CbGeAlD
Loxapine—SLC6A3—telencephalic ventricle—autistic disorder	0.00168	0.0186	CbGeAlD
Loxapine—HTR1D—telencephalic ventricle—autistic disorder	0.00164	0.0182	CbGeAlD
Loxapine—HTR2C—telencephalic ventricle—autistic disorder	0.00162	0.018	CbGeAlD
Loxapine—HTR7—pons—autistic disorder	0.00159	0.0176	CbGeAlD
Loxapine—HTR2A—cerebellar cortex—autistic disorder	0.0014	0.0155	CbGeAlD
Loxapine—HTR1A—telencephalic ventricle—autistic disorder	0.00137	0.0152	CbGeAlD
Loxapine—HTR7—telencephalic ventricle—autistic disorder	0.00131	0.0145	CbGeAlD
Loxapine—HTR5A—head—autistic disorder	0.00125	0.0139	CbGeAlD
Loxapine—DRD2—telencephalic ventricle—autistic disorder	0.00123	0.0137	CbGeAlD
Loxapine—HTR5A—nervous system—autistic disorder	0.00119	0.0132	CbGeAlD
Loxapine—HTR5A—central nervous system—autistic disorder	0.00114	0.0127	CbGeAlD
Loxapine—HTR2A—pons—autistic disorder	0.00099	0.011	CbGeAlD
Loxapine—HTR1E—brainstem—autistic disorder	0.000969	0.0108	CbGeAlD
Loxapine—HTR1E—forebrain—autistic disorder	0.000935	0.0104	CbGeAlD
Loxapine—HTR5A—brain—autistic disorder	0.000909	0.0101	CbGeAlD
Loxapine—HTR1E—telencephalon—autistic disorder	0.00086	0.00954	CbGeAlD
Loxapine—HTR2A—telencephalic ventricle—autistic disorder	0.000815	0.00904	CbGeAlD
Loxapine—SLC6A3—hindbrain—autistic disorder	0.000793	0.0088	CbGeAlD
Loxapine—HTR6—forebrain—autistic disorder	0.000734	0.00814	CbGeAlD
Loxapine—SLC6A4—hindbrain—autistic disorder	0.000727	0.00806	CbGeAlD
Loxapine—DRD5—forebrain—autistic disorder	0.000714	0.00793	CbGeAlD
Loxapine—Asenapine—HTR5A—autistic disorder	0.000695	0.0979	CrCbGaD
Loxapine—HTR6—telencephalon—autistic disorder	0.000675	0.00749	CbGeAlD
Loxapine—DRD5—telencephalon—autistic disorder	0.000657	0.00729	CbGeAlD
Loxapine—CHRM5—eye—autistic disorder	0.000646	0.00717	CbGeAlD
Loxapine—HTR1A—hindbrain—autistic disorder	0.000645	0.00716	CbGeAlD
Loxapine—HTR7—hindbrain—autistic disorder	0.000617	0.00684	CbGeAlD
Loxapine—ADRA1A—hindbrain—autistic disorder	0.000595	0.0066	CbGeAlD
Loxapine—DRD2—hindbrain—autistic disorder	0.000583	0.00647	CbGeAlD
Loxapine—DRD1—brainstem—autistic disorder	0.000566	0.00628	CbGeAlD
Loxapine—HTR3A—brainstem—autistic disorder	0.000546	0.00606	CbGeAlD
Loxapine—DRD1—forebrain—autistic disorder	0.000546	0.00606	CbGeAlD
Loxapine—HTR7—mouth—autistic disorder	0.000541	0.006	CbGeAlD
Loxapine—HTR1E—head—autistic disorder	0.000535	0.00594	CbGeAlD
Loxapine—HTR3A—forebrain—autistic disorder	0.000527	0.00585	CbGeAlD
Loxapine—HTR1E—nervous system—autistic disorder	0.000508	0.00563	CbGeAlD
Loxapine—DRD1—telencephalon—autistic disorder	0.000502	0.00557	CbGeAlD
Loxapine—HTR1E—central nervous system—autistic disorder	0.000489	0.00542	CbGeAlD
Loxapine—HTR3A—telencephalon—autistic disorder	0.000485	0.00538	CbGeAlD
Loxapine—HRH2—digestive system—autistic disorder	0.000471	0.00523	CbGeAlD
Loxapine—CHRM4—head—autistic disorder	0.00047	0.00521	CbGeAlD
Loxapine—HTR1B—brainstem—autistic disorder	0.000458	0.00509	CbGeAlD
Loxapine—SLC6A3—brainstem—autistic disorder	0.000455	0.00504	CbGeAlD
Loxapine—DRD4—brain—autistic disorder	0.00045	0.00499	CbGeAlD
Loxapine—CHRM4—nervous system—autistic disorder	0.000445	0.00494	CbGeAlD
Loxapine—HTR1D—brainstem—autistic disorder	0.000444	0.00492	CbGeAlD
Loxapine—HTR1B—forebrain—autistic disorder	0.000442	0.00491	CbGeAlD
Loxapine—CHRM2—forebrain—autistic disorder	0.00044	0.00488	CbGeAlD
Loxapine—HTR2C—brainstem—autistic disorder	0.000439	0.00488	CbGeAlD
Loxapine—SLC6A3—forebrain—autistic disorder	0.000439	0.00487	CbGeAlD
Loxapine—DRD3—head—autistic disorder	0.000436	0.00484	CbGeAlD
Loxapine—HTR1D—eye—autistic disorder	0.000432	0.00479	CbGeAlD
Loxapine—CHRM4—central nervous system—autistic disorder	0.000429	0.00476	CbGeAlD
Loxapine—HTR1D—forebrain—autistic disorder	0.000428	0.00475	CbGeAlD
Loxapine—HTR2C—forebrain—autistic disorder	0.000424	0.00471	CbGeAlD
Loxapine—HTR6—head—autistic disorder	0.00042	0.00466	CbGeAlD
Loxapine—SLC6A4—brainstem—autistic disorder	0.000417	0.00462	CbGeAlD
Loxapine—ADRB1—forebrain—autistic disorder	0.000416	0.00462	CbGeAlD
Loxapine—DRD3—nervous system—autistic disorder	0.000414	0.00459	CbGeAlD
Loxapine—DRD5—head—autistic disorder	0.000409	0.00454	CbGeAlD
Loxapine—HTR1B—telencephalon—autistic disorder	0.000407	0.00451	CbGeAlD
Loxapine—CHRM2—telencephalon—autistic disorder	0.000405	0.00449	CbGeAlD
Loxapine—SLC6A3—telencephalon—autistic disorder	0.000403	0.00448	CbGeAlD
Loxapine—SLC6A4—forebrain—autistic disorder	0.000402	0.00446	CbGeAlD
Loxapine—CHRM1—forebrain—autistic disorder	0.0004	0.00444	CbGeAlD
Loxapine—DRD3—central nervous system—autistic disorder	0.000398	0.00442	CbGeAlD
Loxapine—HTR6—nervous system—autistic disorder	0.000398	0.00442	CbGeAlD
Loxapine—HTR1D—telencephalon—autistic disorder	0.000394	0.00437	CbGeAlD
Loxapine—HTR2C—telencephalon—autistic disorder	0.00039	0.00433	CbGeAlD
Loxapine—HTR1E—brain—autistic disorder	0.000388	0.00431	CbGeAlD
Loxapine—DRD5—nervous system—autistic disorder	0.000388	0.0043	CbGeAlD
Loxapine—Olanzapine—HTR5A—autistic disorder	0.000387	0.0545	CrCbGaD
Loxapine—HTR2A—hindbrain—autistic disorder	0.000385	0.00427	CbGeAlD
Loxapine—HRH2—head—autistic disorder	0.000384	0.00426	CbGeAlD
Loxapine—HTR6—central nervous system—autistic disorder	0.000384	0.00426	CbGeAlD
Loxapine—ADRB1—telencephalon—autistic disorder	0.000383	0.00425	CbGeAlD
Loxapine—DRD5—central nervous system—autistic disorder	0.000373	0.00414	CbGeAlD
Loxapine—HTR3A—digestive system—autistic disorder	0.00037	0.00411	CbGeAlD
Loxapine—HTR1A—brainstem—autistic disorder	0.00037	0.0041	CbGeAlD
Loxapine—SLC6A4—telencephalon—autistic disorder	0.00037	0.0041	CbGeAlD
Loxapine—CHRM1—telencephalon—autistic disorder	0.000368	0.00409	CbGeAlD
Loxapine—CHRM5—head—autistic disorder	0.000367	0.00407	CbGeAlD
Loxapine—SLC6A2—brainstem—autistic disorder	0.000367	0.00407	CbGeAlD
Loxapine—HRH2—nervous system—autistic disorder	0.000364	0.00404	CbGeAlD
Loxapine—CHRM3—forebrain—autistic disorder	0.000358	0.00398	CbGeAlD
Loxapine—HTR1A—forebrain—autistic disorder	0.000357	0.00396	CbGeAlD
Loxapine—SLC6A2—forebrain—autistic disorder	0.000354	0.00393	CbGeAlD
Loxapine—HTR7—brainstem—autistic disorder	0.000353	0.00392	CbGeAlD
Loxapine—HRH2—central nervous system—autistic disorder	0.000351	0.00389	CbGeAlD
Loxapine—CHRM5—nervous system—autistic disorder	0.000348	0.00386	CbGeAlD
Loxapine—HTR7—forebrain—autistic disorder	0.000341	0.00379	CbGeAlD
Loxapine—ADRA1A—brainstem—autistic disorder	0.000341	0.00378	CbGeAlD
Loxapine—CHRM4—brain—autistic disorder	0.00034	0.00378	CbGeAlD
Loxapine—ADRA1B—head—autistic disorder	0.000335	0.00372	CbGeAlD
Loxapine—CHRM5—central nervous system—autistic disorder	0.000335	0.00372	CbGeAlD
Loxapine—DRD2—brainstem—autistic disorder	0.000334	0.00371	CbGeAlD
Loxapine—CHRM3—telencephalon—autistic disorder	0.00033	0.00366	CbGeAlD
Loxapine—ADRA1A—forebrain—autistic disorder	0.000329	0.00365	CbGeAlD
Loxapine—HTR1A—telencephalon—autistic disorder	0.000328	0.00364	CbGeAlD
Loxapine—SLC6A2—telencephalon—autistic disorder	0.000325	0.00361	CbGeAlD
Loxapine—DRD2—eye—autistic disorder	0.000325	0.00361	CbGeAlD
Loxapine—DRD2—forebrain—autistic disorder	0.000323	0.00358	CbGeAlD
Loxapine—ADRA1B—nervous system—autistic disorder	0.000318	0.00353	CbGeAlD
Loxapine—DRD3—brain—autistic disorder	0.000316	0.00351	CbGeAlD
Loxapine—HTR7—telencephalon—autistic disorder	0.000314	0.00348	CbGeAlD
Loxapine—DRD1—head—autistic disorder	0.000313	0.00347	CbGeAlD
Loxapine—ADRA1B—central nervous system—autistic disorder	0.000306	0.0034	CbGeAlD
Loxapine—HTR6—brain—autistic disorder	0.000304	0.00338	CbGeAlD
Loxapine—ADRA1A—telencephalon—autistic disorder	0.000303	0.00336	CbGeAlD
Loxapine—HTR3A—head—autistic disorder	0.000302	0.00335	CbGeAlD
Loxapine—DRD2—telencephalon—autistic disorder	0.000297	0.00329	CbGeAlD
Loxapine—DRD5—brain—autistic disorder	0.000296	0.00329	CbGeAlD
Loxapine—DRD1—nervous system—autistic disorder	0.000296	0.00329	CbGeAlD
Loxapine—ADRA2C—telencephalon—autistic disorder	0.000288	0.0032	CbGeAlD
Loxapine—HTR3A—nervous system—autistic disorder	0.000286	0.00318	CbGeAlD
Loxapine—DRD1—central nervous system—autistic disorder	0.000285	0.00317	CbGeAlD
Loxapine—SLC6A4—digestive system—autistic disorder	0.000282	0.00313	CbGeAlD
Loxapine—HRH2—brain—autistic disorder	0.000278	0.00309	CbGeAlD
Loxapine—HTR3A—central nervous system—autistic disorder	0.000276	0.00306	CbGeAlD
Loxapine—CHRM5—brain—autistic disorder	0.000266	0.00295	CbGeAlD
Loxapine—HRH1—eye—autistic disorder	0.000257	0.00285	CbGeAlD
Loxapine—HRH1—forebrain—autistic disorder	0.000255	0.00283	CbGeAlD
Loxapine—HTR1B—head—autistic disorder	0.000253	0.00281	CbGeAlD
Loxapine—CHRM2—head—autistic disorder	0.000252	0.0028	CbGeAlD
Loxapine—CHRM3—digestive system—autistic disorder	0.000252	0.00279	CbGeAlD
Loxapine—SLC6A3—head—autistic disorder	0.000251	0.00279	CbGeAlD
Loxapine—ADRA2A—forebrain—autistic disorder	0.00025	0.00278	CbGeAlD
Loxapine—HTR1D—head—autistic disorder	0.000245	0.00272	CbGeAlD
Loxapine—ADRA1B—brain—autistic disorder	0.000243	0.0027	CbGeAlD
Loxapine—HTR2C—head—autistic disorder	0.000243	0.00269	CbGeAlD
Loxapine—HTR1B—nervous system—autistic disorder	0.00024	0.00266	CbGeAlD
Loxapine—HTR7—digestive system—autistic disorder	0.000239	0.00266	CbGeAlD
Loxapine—CHRM2—nervous system—autistic disorder	0.000239	0.00265	CbGeAlD
Loxapine—ADRB1—head—autistic disorder	0.000238	0.00264	CbGeAlD
Loxapine—SLC6A3—nervous system—autistic disorder	0.000238	0.00264	CbGeAlD
Loxapine—HRH1—telencephalon—autistic disorder	0.000234	0.0026	CbGeAlD
Loxapine—HTR1D—nervous system—autistic disorder	0.000232	0.00258	CbGeAlD
Loxapine—HTR1B—central nervous system—autistic disorder	0.000231	0.00257	CbGeAlD
Loxapine—HTR2C—nervous system—autistic disorder	0.00023	0.00255	CbGeAlD
Loxapine—SLC6A4—head—autistic disorder	0.00023	0.00255	CbGeAlD
Loxapine—ADRA2A—telencephalon—autistic disorder	0.00023	0.00255	CbGeAlD
Loxapine—CHRM2—central nervous system—autistic disorder	0.00023	0.00255	CbGeAlD
Loxapine—CHRM1—head—autistic disorder	0.000229	0.00254	CbGeAlD
Loxapine—SLC6A3—central nervous system—autistic disorder	0.000229	0.00254	CbGeAlD
Loxapine—DRD1—brain—autistic disorder	0.000227	0.00251	CbGeAlD
Loxapine—ADRB1—nervous system—autistic disorder	0.000226	0.00251	CbGeAlD
Loxapine—SLC6A3—cerebellum—autistic disorder	0.000224	0.00249	CbGeAlD
Loxapine—HTR1D—central nervous system—autistic disorder	0.000224	0.00248	CbGeAlD
Loxapine—HTR2C—central nervous system—autistic disorder	0.000222	0.00246	CbGeAlD
Loxapine—HTR2A—brainstem—autistic disorder	0.00022	0.00245	CbGeAlD
Loxapine—HTR3A—brain—autistic disorder	0.000219	0.00243	CbGeAlD
Loxapine—SLC6A4—nervous system—autistic disorder	0.000218	0.00242	CbGeAlD
Loxapine—ADRB1—central nervous system—autistic disorder	0.000217	0.00241	CbGeAlD
Loxapine—CHRM1—nervous system—autistic disorder	0.000217	0.00241	CbGeAlD
Loxapine—HTR2A—eye—autistic disorder	0.000215	0.00238	CbGeAlD
Loxapine—HTR2A—forebrain—autistic disorder	0.000213	0.00236	CbGeAlD
Loxapine—SLC6A4—central nervous system—autistic disorder	0.00021	0.00233	CbGeAlD
Loxapine—CHRM1—central nervous system—autistic disorder	0.000209	0.00232	CbGeAlD
Loxapine—CHRM3—head—autistic disorder	0.000205	0.00228	CbGeAlD
Loxapine—HTR1A—head—autistic disorder	0.000204	0.00227	CbGeAlD
Loxapine—SLC6A2—head—autistic disorder	0.000203	0.00225	CbGeAlD
Loxapine—HTR2A—telencephalon—autistic disorder	0.000196	0.00217	CbGeAlD
Loxapine—HTR7—head—autistic disorder	0.000195	0.00217	CbGeAlD
Loxapine—CHRM3—nervous system—autistic disorder	0.000195	0.00216	CbGeAlD
Loxapine—HTR1A—nervous system—autistic disorder	0.000194	0.00215	CbGeAlD
Loxapine—Asenapine—HTR1D—autistic disorder	0.000193	0.0272	CrCbGaD
Loxapine—SLC6A2—nervous system—autistic disorder	0.000192	0.00213	CbGeAlD
Loxapine—ADRA1A—head—autistic disorder	0.000188	0.00209	CbGeAlD
Loxapine—CHRM3—central nervous system—autistic disorder	0.000187	0.00208	CbGeAlD
Loxapine—HTR1A—central nervous system—autistic disorder	0.000187	0.00207	CbGeAlD
Loxapine—HTR7—nervous system—autistic disorder	0.000185	0.00206	CbGeAlD
Loxapine—SLC6A2—central nervous system—autistic disorder	0.000185	0.00205	CbGeAlD
Loxapine—DRD2—head—autistic disorder	0.000185	0.00205	CbGeAlD
Loxapine—HTR1B—brain—autistic disorder	0.000184	0.00204	CbGeAlD
Loxapine—CHRM2—brain—autistic disorder	0.000183	0.00203	CbGeAlD
Loxapine—HTR1A—cerebellum—autistic disorder	0.000182	0.00202	CbGeAlD
Loxapine—SLC6A3—brain—autistic disorder	0.000182	0.00202	CbGeAlD
Loxapine—ADRA2C—head—autistic disorder	0.00018	0.00199	CbGeAlD
Loxapine—HRH1—digestive system—autistic disorder	0.000179	0.00198	CbGeAlD
Loxapine—ADRA1A—nervous system—autistic disorder	0.000179	0.00198	CbGeAlD
Loxapine—HTR7—central nervous system—autistic disorder	0.000178	0.00198	CbGeAlD
Loxapine—HTR1D—brain—autistic disorder	0.000178	0.00197	CbGeAlD
Loxapine—HTR2C—brain—autistic disorder	0.000176	0.00195	CbGeAlD
Loxapine—DRD2—nervous system—autistic disorder	0.000175	0.00194	CbGeAlD
Loxapine—HTR7—cerebellum—autistic disorder	0.000174	0.00193	CbGeAlD
Loxapine—ADRB1—brain—autistic disorder	0.000173	0.00192	CbGeAlD
Loxapine—ADRA1A—central nervous system—autistic disorder	0.000172	0.00191	CbGeAlD
Loxapine—ADRA2C—nervous system—autistic disorder	0.00017	0.00189	CbGeAlD
Loxapine—DRD2—central nervous system—autistic disorder	0.000169	0.00187	CbGeAlD
Loxapine—ADRA1A—cerebellum—autistic disorder	0.000168	0.00187	CbGeAlD
Loxapine—SLC6A4—brain—autistic disorder	0.000167	0.00185	CbGeAlD
Loxapine—CHRM1—brain—autistic disorder	0.000166	0.00184	CbGeAlD
Loxapine—DRD2—cerebellum—autistic disorder	0.000165	0.00183	CbGeAlD
Loxapine—ADRA2C—central nervous system—autistic disorder	0.000164	0.00182	CbGeAlD
Loxapine—ADRA2C—cerebellum—autistic disorder	0.00016	0.00178	CbGeAlD
Loxapine—HTR2A—digestive system—autistic disorder	0.000149	0.00166	CbGeAlD
Loxapine—CHRM3—brain—autistic disorder	0.000149	0.00165	CbGeAlD
Loxapine—HTR1A—brain—autistic disorder	0.000148	0.00164	CbGeAlD
Loxapine—SLC6A2—brain—autistic disorder	0.000147	0.00163	CbGeAlD
Loxapine—HRH1—head—autistic disorder	0.000146	0.00162	CbGeAlD
Loxapine—ADRA2A—head—autistic disorder	0.000143	0.00159	CbGeAlD
Loxapine—HTR7—brain—autistic disorder	0.000142	0.00157	CbGeAlD
Loxapine—HRH1—nervous system—autistic disorder	0.000138	0.00153	CbGeAlD
Loxapine—ADRA1A—brain—autistic disorder	0.000137	0.00152	CbGeAlD
Loxapine—ADRA2A—nervous system—autistic disorder	0.000136	0.00151	CbGeAlD
Loxapine—DRD2—brain—autistic disorder	0.000134	0.00149	CbGeAlD
Loxapine—HRH1—central nervous system—autistic disorder	0.000133	0.00148	CbGeAlD
Loxapine—ADRA2A—central nervous system—autistic disorder	0.000131	0.00145	CbGeAlD
Loxapine—ADRA2C—brain—autistic disorder	0.00013	0.00144	CbGeAlD
Loxapine—ADRA2A—cerebellum—autistic disorder	0.000128	0.00142	CbGeAlD
Loxapine—HTR2A—head—autistic disorder	0.000122	0.00135	CbGeAlD
Loxapine—Fludiazepam—GABRG3—autistic disorder	0.000119	0.0168	CrCbGaD
Loxapine—Prazepam—GABRG3—autistic disorder	0.000116	0.0164	CrCbGaD
Loxapine—HTR2A—nervous system—autistic disorder	0.000115	0.00128	CbGeAlD
Loxapine—Asenapine—HTR1B—autistic disorder	0.000114	0.0161	CrCbGaD
Loxapine—HTR2A—central nervous system—autistic disorder	0.000111	0.00123	CbGeAlD
Loxapine—Asenapine—DRD3—autistic disorder	0.000111	0.0156	CrCbGaD
Loxapine—Asenapine—DRD1—autistic disorder	0.000109	0.0154	CrCbGaD
Loxapine—HTR2A—cerebellum—autistic disorder	0.000109	0.00121	CbGeAlD
Loxapine—Olanzapine—HTR3A—autistic disorder	0.000108	0.0153	CrCbGaD
Loxapine—Chlordiazepoxide—GABRB3—autistic disorder	0.000108	0.0152	CrCbGaD
Loxapine—Chlordiazepoxide—GABRA5—autistic disorder	0.000108	0.0152	CrCbGaD
Loxapine—Olanzapine—HTR1D—autistic disorder	0.000107	0.0151	CrCbGaD
Loxapine—Chlordiazepoxide—GABRA3—autistic disorder	0.000106	0.0149	CrCbGaD
Loxapine—HRH1—brain—autistic disorder	0.000106	0.00117	CbGeAlD
Loxapine—ADRA2A—brain—autistic disorder	0.000104	0.00115	CbGeAlD
Loxapine—Temazepam—GABRG3—autistic disorder	0.000104	0.0146	CrCbGaD
Loxapine—Chlordiazepoxide—GABRB2—autistic disorder	9.45e-05	0.0133	CrCbGaD
Loxapine—Chlordiazepoxide—GABRA1—autistic disorder	9.27e-05	0.0131	CrCbGaD
Loxapine—Alprazolam—GABRA5—autistic disorder	9.15e-05	0.0129	CrCbGaD
Loxapine—Alprazolam—GABRB3—autistic disorder	9.15e-05	0.0129	CrCbGaD
Loxapine—Alprazolam—GABRA3—autistic disorder	8.98e-05	0.0127	CrCbGaD
Loxapine—Fludiazepam—GABRB1—autistic disorder	8.9e-05	0.0125	CrCbGaD
Loxapine—Chlordiazepoxide—GABRA2—autistic disorder	8.86e-05	0.0125	CrCbGaD
Loxapine—HTR2A—brain—autistic disorder	8.83e-05	0.00098	CbGeAlD
Loxapine—Prazepam—GABRB1—autistic disorder	8.68e-05	0.0122	CrCbGaD
Loxapine—Amoxapine—HTR3A—autistic disorder	8.63e-05	0.0122	CrCbGaD
Loxapine—Diazepam—GABRG3—autistic disorder	8.62e-05	0.0121	CrCbGaD
Loxapine—Asenapine—ADRB2—autistic disorder	8.51e-05	0.012	CrCbGaD
Loxapine—Alprazolam—GABRB2—autistic disorder	8e-05	0.0113	CrCbGaD
Loxapine—Clobazam—GABRB2—autistic disorder	8e-05	0.0113	CrCbGaD
Loxapine—Clobazam—GABRA1—autistic disorder	7.85e-05	0.0111	CrCbGaD
Loxapine—Alprazolam—GABRA1—autistic disorder	7.85e-05	0.0111	CrCbGaD
Loxapine—Temazepam—GABRB1—autistic disorder	7.74e-05	0.0109	CrCbGaD
Loxapine—Asenapine—SLC6A4—autistic disorder	7.73e-05	0.0109	CrCbGaD
Loxapine—Trifluoperazine—XDH—autistic disorder	7.61e-05	0.0107	CrCbGaD
Loxapine—Alprazolam—GABRA2—autistic disorder	7.5e-05	0.0106	CrCbGaD
Loxapine—Fludiazepam—GABRA5—autistic disorder	7.38e-05	0.0104	CrCbGaD
Loxapine—Fludiazepam—GABRB3—autistic disorder	7.38e-05	0.0104	CrCbGaD
Loxapine—Fludiazepam—GABRA3—autistic disorder	7.25e-05	0.0102	CrCbGaD
Loxapine—Temazepam—GABRA4—autistic disorder	7.23e-05	0.0102	CrCbGaD
Loxapine—Prazepam—GABRA5—autistic disorder	7.21e-05	0.0102	CrCbGaD
Loxapine—Prazepam—GABRB3—autistic disorder	7.21e-05	0.0102	CrCbGaD
Loxapine—Prazepam—GABRA3—autistic disorder	7.08e-05	0.00997	CrCbGaD
Loxapine—Amoxapine—GABRA1—autistic disorder	6.9e-05	0.00972	CrCbGaD
Loxapine—Quetiapine—HTR3A—autistic disorder	6.58e-05	0.00927	CrCbGaD
Loxapine—Quetiapine—HTR1D—autistic disorder	6.51e-05	0.00917	CrCbGaD
Loxapine—Fludiazepam—GABRB2—autistic disorder	6.46e-05	0.00911	CrCbGaD
Loxapine—Diazepam—GABRB1—autistic disorder	6.43e-05	0.00906	CrCbGaD
Loxapine—Temazepam—GABRA5—autistic disorder	6.43e-05	0.00905	CrCbGaD
Loxapine—Temazepam—GABRB3—autistic disorder	6.43e-05	0.00905	CrCbGaD
Loxapine—Zuclopenthixol—DRD1—autistic disorder	6.37e-05	0.00897	CrCbGaD
Loxapine—Olanzapine—HTR1B—autistic disorder	6.36e-05	0.00897	CrCbGaD
Loxapine—Fludiazepam—GABRA1—autistic disorder	6.34e-05	0.00893	CrCbGaD
Loxapine—Temazepam—GABRA3—autistic disorder	6.31e-05	0.00889	CrCbGaD
Loxapine—Prazepam—GABRB2—autistic disorder	6.31e-05	0.00889	CrCbGaD
Loxapine—Prazepam—GABRA1—autistic disorder	6.19e-05	0.00872	CrCbGaD
Loxapine—Olanzapine—DRD3—autistic disorder	6.18e-05	0.0087	CrCbGaD
Loxapine—Olanzapine—DRD1—autistic disorder	6.06e-05	0.00854	CrCbGaD
Loxapine—Fludiazepam—GABRA2—autistic disorder	6.06e-05	0.00854	CrCbGaD
Loxapine—Asenapine—HTR2A—autistic disorder	5.94e-05	0.00837	CrCbGaD
Loxapine—Prazepam—GABRA2—autistic disorder	5.91e-05	0.00833	CrCbGaD
Loxapine—Clozapine—HTR3A—autistic disorder	5.66e-05	0.00797	CrCbGaD
Loxapine—Temazepam—GABRB2—autistic disorder	5.62e-05	0.00792	CrCbGaD
Loxapine—Clozapine—HTR1D—autistic disorder	5.6e-05	0.00789	CrCbGaD
Loxapine—Temazepam—GABRA1—autistic disorder	5.52e-05	0.00777	CrCbGaD
Loxapine—Thiothixene—DRD1—autistic disorder	5.49e-05	0.00774	CrCbGaD
Loxapine—Prochlorperazine—DRD3—autistic disorder	5.35e-05	0.00753	CrCbGaD
Loxapine—Diazepam—GABRA5—autistic disorder	5.34e-05	0.00752	CrCbGaD
Loxapine—Diazepam—GABRB3—autistic disorder	5.34e-05	0.00752	CrCbGaD
Loxapine—Temazepam—GABRA2—autistic disorder	5.27e-05	0.00743	CrCbGaD
Loxapine—Diazepam—GABRA3—autistic disorder	5.24e-05	0.00739	CrCbGaD
Loxapine—Amoxapine—HTR1B—autistic disorder	5.07e-05	0.00714	CrCbGaD
Loxapine—Amoxapine—DRD3—autistic disorder	4.92e-05	0.00693	CrCbGaD
Loxapine—Amoxapine—DRD1—autistic disorder	4.83e-05	0.0068	CrCbGaD
Loxapine—Diazepam—GABRB2—autistic disorder	4.67e-05	0.00658	CrCbGaD
Loxapine—Diazepam—GABRA1—autistic disorder	4.58e-05	0.00646	CrCbGaD
Loxapine—Diazepam—GABRA2—autistic disorder	4.38e-05	0.00617	CrCbGaD
Loxapine—Trazodone—SLC6A4—autistic disorder	4.15e-05	0.00585	CrCbGaD
Loxapine—Quetiapine—HTR1B—autistic disorder	3.86e-05	0.00544	CrCbGaD
Loxapine—Quetiapine—DRD3—autistic disorder	3.75e-05	0.00528	CrCbGaD
Loxapine—Quetiapine—DRD1—autistic disorder	3.68e-05	0.00518	CrCbGaD
Loxapine—Zuclopenthixol—HTR2A—autistic disorder	3.47e-05	0.00489	CrCbGaD
Loxapine—Amoxapine—SLC6A4—autistic disorder	3.42e-05	0.00482	CrCbGaD
Loxapine—Cyproheptadine—HTR2A—autistic disorder	3.41e-05	0.00481	CrCbGaD
Loxapine—Clozapine—HTR1B—autistic disorder	3.32e-05	0.00468	CrCbGaD
Loxapine—Olanzapine—HTR2A—autistic disorder	3.3e-05	0.00465	CrCbGaD
Loxapine—Clozapine—DRD3—autistic disorder	3.22e-05	0.00454	CrCbGaD
Loxapine—Trazodone—HTR2A—autistic disorder	3.19e-05	0.0045	CrCbGaD
Loxapine—Clozapine—DRD1—autistic disorder	3.16e-05	0.00446	CrCbGaD
Loxapine—Thiothixene—HTR2A—autistic disorder	2.99e-05	0.00421	CrCbGaD
Loxapine—Amoxapine—HTR2A—autistic disorder	2.63e-05	0.0037	CrCbGaD
Loxapine—Trifluoperazine—HTR2A—autistic disorder	2.07e-05	0.00291	CrCbGaD
Loxapine—Quetiapine—HTR2A—autistic disorder	2e-05	0.00282	CrCbGaD
Loxapine—Clozapine—HTR2A—autistic disorder	1.72e-05	0.00243	CrCbGaD
Loxapine—ADRA1A—Signaling Pathways—LEP—autistic disorder	1.63e-06	1.04e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—APOE—autistic disorder	1.63e-06	1.04e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	1.63e-06	1.04e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL2—autistic disorder	1.62e-06	1.04e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—HRAS—autistic disorder	1.62e-06	1.03e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL2—autistic disorder	1.6e-06	1.03e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—POMC—autistic disorder	1.6e-06	1.02e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—IL6—autistic disorder	1.59e-06	1.02e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PRKCB—autistic disorder	1.59e-06	1.02e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IGF1—autistic disorder	1.59e-06	1.02e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	1.58e-06	1.01e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IGF1—autistic disorder	1.58e-06	1.01e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL2—autistic disorder	1.58e-06	1.01e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.58e-06	1.01e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	1.57e-06	1.01e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—POMC—autistic disorder	1.57e-06	1.01e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—IL6—autistic disorder	1.57e-06	1e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PRKCB—autistic disorder	1.57e-06	1e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PRKCB—autistic disorder	1.56e-06	1e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—SERPINE1—autistic disorder	1.56e-06	1e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PRKCB—autistic disorder	1.56e-06	9.97e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL2—autistic disorder	1.56e-06	9.95e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PRKCB—autistic disorder	1.55e-06	9.93e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—POMC—autistic disorder	1.55e-06	9.93e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—PTEN—autistic disorder	1.55e-06	9.93e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—PTEN—autistic disorder	1.55e-06	9.92e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—HRAS—autistic disorder	1.55e-06	9.91e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—IL6—autistic disorder	1.55e-06	9.9e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TSC2—autistic disorder	1.54e-06	9.88e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—PTEN—autistic disorder	1.54e-06	9.85e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PRKCB—autistic disorder	1.54e-06	9.84e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IGF1—autistic disorder	1.54e-06	9.83e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	1.53e-06	9.81e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—MAPK1—autistic disorder	1.53e-06	9.79e-06	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PTGS2—autistic disorder	1.52e-06	9.75e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—APC—autistic disorder	1.52e-06	9.74e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PIK3CG—autistic disorder	1.52e-06	9.74e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IGF1—autistic disorder	1.51e-06	9.68e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—APOE—autistic disorder	1.51e-06	9.67e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—LEP—autistic disorder	1.51e-06	9.67e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	1.51e-06	9.65e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—PTEN—autistic disorder	1.51e-06	9.65e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EGF—autistic disorder	1.51e-06	9.63e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	1.51e-06	9.63e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	1.5e-06	9.6e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—APC—autistic disorder	1.5e-06	9.59e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	1.5e-06	9.59e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PIK3CG—autistic disorder	1.5e-06	9.57e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—APC—autistic disorder	1.5e-06	9.57e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—APC—autistic disorder	1.49e-06	9.54e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	1.49e-06	9.54e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL2—autistic disorder	1.49e-06	9.53e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—APC—autistic disorder	1.49e-06	9.51e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PIK3CG—autistic disorder	1.49e-06	9.51e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—PTEN—autistic disorder	1.48e-06	9.49e-06	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—HRAS—autistic disorder	1.48e-06	9.49e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—IL6—autistic disorder	1.48e-06	9.48e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EGF—autistic disorder	1.48e-06	9.48e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EGF—autistic disorder	1.48e-06	9.46e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—HRAS—autistic disorder	1.48e-06	9.44e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EGF—autistic disorder	1.47e-06	9.43e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—APC—autistic disorder	1.47e-06	9.41e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	1.47e-06	9.41e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EGF—autistic disorder	1.47e-06	9.4e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—APC—autistic disorder	1.47e-06	9.39e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	1.47e-06	9.39e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—PTEN—autistic disorder	1.46e-06	9.37e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—SERPINE1—autistic disorder	1.46e-06	9.34e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—HRAS—autistic disorder	1.46e-06	9.32e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EGF—autistic disorder	1.45e-06	9.31e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EGF—autistic disorder	1.45e-06	9.28e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—POMC—autistic disorder	1.45e-06	9.28e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	1.44e-06	9.19e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—POMC—autistic disorder	1.43e-06	9.13e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	1.42e-06	9.12e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—POMC—autistic disorder	1.42e-06	9.11e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL2—autistic disorder	1.42e-06	9.08e-06	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—IL6—autistic disorder	1.42e-06	9.08e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—POMC—autistic disorder	1.42e-06	9.08e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—POMC—autistic disorder	1.41e-06	9.05e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—IL6—autistic disorder	1.41e-06	9.04e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—PTEN—autistic disorder	1.4e-06	8.97e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL2—autistic disorder	1.4e-06	8.96e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—POMC—autistic disorder	1.4e-06	8.96e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—POMC—autistic disorder	1.4e-06	8.94e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IGF1—autistic disorder	1.39e-06	8.92e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—IL6—autistic disorder	1.39e-06	8.92e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—MAPK1—autistic disorder	1.39e-06	8.88e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IGF1—autistic disorder	1.37e-06	8.78e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IGF1—autistic disorder	1.37e-06	8.76e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	1.37e-06	8.74e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IGF1—autistic disorder	1.36e-06	8.73e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—APC—autistic disorder	1.36e-06	8.72e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	1.36e-06	8.72e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—MAPK1—autistic disorder	1.36e-06	8.72e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IGF1—autistic disorder	1.36e-06	8.7e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	1.36e-06	8.69e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—MAPK1—autistic disorder	1.35e-06	8.66e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTGS2—autistic disorder	1.35e-06	8.63e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EGF—autistic disorder	1.35e-06	8.62e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IGF1—autistic disorder	1.35e-06	8.62e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IGF1—autistic disorder	1.34e-06	8.6e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	1.34e-06	8.58e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	1.34e-06	8.56e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—PTEN—autistic disorder	1.34e-06	8.55e-06	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PTEN—autistic disorder	1.33e-06	8.5e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.33e-06	8.49e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—SERPINE1—autistic disorder	1.32e-06	8.47e-06	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—HRAS—autistic disorder	1.32e-06	8.45e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—PTEN—autistic disorder	1.32e-06	8.43e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—HRAS—autistic disorder	1.31e-06	8.41e-06	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—HRAS—autistic disorder	1.31e-06	8.39e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	1.3e-06	8.34e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SERPINE1—autistic disorder	1.3e-06	8.32e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—POMC—autistic disorder	1.3e-06	8.3e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	1.3e-06	8.29e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SERPINE1—autistic disorder	1.29e-06	8.27e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	1.28e-06	8.19e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL2—autistic disorder	1.28e-06	8.17e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	1.28e-06	8.16e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.27e-06	8.12e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—HRAS—autistic disorder	1.27e-06	8.12e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL2—autistic disorder	1.26e-06	8.09e-06	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—IL6—autistic disorder	1.26e-06	8.09e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—HRAS—autistic disorder	1.26e-06	8.08e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MAPK1—autistic disorder	1.26e-06	8.07e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MAPK1—autistic disorder	1.26e-06	8.06e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—IL6—autistic disorder	1.26e-06	8.05e-06	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—IL6—autistic disorder	1.26e-06	8.03e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MAPK1—autistic disorder	1.25e-06	8.01e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IGF1—autistic disorder	1.25e-06	7.99e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	1.24e-06	7.95e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—autistic disorder	1.24e-06	7.92e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—HRAS—autistic disorder	1.23e-06	7.86e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MAPK1—autistic disorder	1.23e-06	7.84e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL2—autistic disorder	1.22e-06	7.81e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—IL6—autistic disorder	1.21e-06	7.77e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL2—autistic disorder	1.21e-06	7.77e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	1.21e-06	7.73e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—IL6—autistic disorder	1.21e-06	7.73e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MAPK1—autistic disorder	1.21e-06	7.72e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.2e-06	7.68e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MAPK1—autistic disorder	1.19e-06	7.61e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—PTEN—autistic disorder	1.19e-06	7.61e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	1.19e-06	7.58e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL2—autistic disorder	1.18e-06	7.56e-06	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTEN—autistic disorder	1.18e-06	7.53e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—IL6—autistic disorder	1.18e-06	7.52e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL2—autistic disorder	1.16e-06	7.44e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—IL6—autistic disorder	1.16e-06	7.4e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—PTEN—autistic disorder	1.15e-06	7.35e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—PTEN—autistic disorder	1.14e-06	7.31e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MAPK1—autistic disorder	1.14e-06	7.29e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—HRAS—autistic disorder	1.11e-06	7.13e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—PTEN—autistic disorder	1.11e-06	7.11e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—HRAS—autistic disorder	1.1e-06	7.01e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—HRAS—autistic disorder	1.09e-06	7e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—PTEN—autistic disorder	1.09e-06	7e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—HRAS—autistic disorder	1.09e-06	6.98e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—HRAS—autistic disorder	1.09e-06	6.95e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MAPK1—autistic disorder	1.09e-06	6.95e-06	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTEN—autistic disorder	1.08e-06	6.91e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—HRAS—autistic disorder	1.08e-06	6.89e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	1.07e-06	6.87e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL2—autistic disorder	1.07e-06	6.86e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MAPK1—autistic disorder	1.07e-06	6.86e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—IL6—autistic disorder	1.07e-06	6.82e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL2—autistic disorder	1.05e-06	6.75e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL2—autistic disorder	1.05e-06	6.73e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—IL6—autistic disorder	1.05e-06	6.71e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL2—autistic disorder	1.05e-06	6.71e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—IL6—autistic disorder	1.05e-06	6.7e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL2—autistic disorder	1.05e-06	6.69e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL6—autistic disorder	1.04e-06	6.68e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL6—autistic disorder	1.04e-06	6.66e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL2—autistic disorder	1.04e-06	6.62e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL2—autistic disorder	1.03e-06	6.61e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL6—autistic disorder	1.03e-06	6.59e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL6—autistic disorder	1.03e-06	6.57e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—HRAS—autistic disorder	1.01e-06	6.48e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—HRAS—autistic disorder	1.01e-06	6.47e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PTEN—autistic disorder	1.01e-06	6.45e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—HRAS—autistic disorder	1.01e-06	6.43e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	9.97e-07	6.38e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PTEN—autistic disorder	9.92e-07	6.35e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PTEN—autistic disorder	9.9e-07	6.34e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PTEN—autistic disorder	9.87e-07	6.31e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—HRAS—autistic disorder	9.84e-07	6.3e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PTEN—autistic disorder	9.84e-07	6.29e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MAPK1—autistic disorder	9.76e-07	6.25e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PTEN—autistic disorder	9.74e-07	6.23e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PTEN—autistic disorder	9.72e-07	6.22e-06	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL6—autistic disorder	9.69e-07	6.2e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—HRAS—autistic disorder	9.68e-07	6.2e-06	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL6—autistic disorder	9.68e-07	6.19e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MAPK1—autistic disorder	9.67e-07	6.19e-06	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL6—autistic disorder	9.62e-07	6.15e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL2—autistic disorder	9.59e-07	6.14e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—HRAS—autistic disorder	9.55e-07	6.11e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL6—autistic disorder	9.55e-07	6.11e-06	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL6—autistic disorder	9.42e-07	6.03e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MAPK1—autistic disorder	9.34e-07	5.97e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MAPK1—autistic disorder	9.29e-07	5.94e-06	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL6—autistic disorder	9.27e-07	5.93e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—HRAS—autistic disorder	9.15e-07	5.85e-06	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL6—autistic disorder	9.14e-07	5.85e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MAPK1—autistic disorder	9.04e-07	5.78e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PTEN—autistic disorder	9.03e-07	5.78e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	8.89e-07	5.69e-06	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL6—autistic disorder	8.76e-07	5.6e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—HRAS—autistic disorder	8.72e-07	5.58e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—HRAS—autistic disorder	8.6e-07	5.5e-06	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL6—autistic disorder	8.34e-07	5.34e-06	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL6—autistic disorder	8.23e-07	5.27e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MAPK1—autistic disorder	8.2e-07	5.25e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MAPK1—autistic disorder	8.07e-07	5.16e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MAPK1—autistic disorder	8.05e-07	5.15e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MAPK1—autistic disorder	8.02e-07	5.13e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MAPK1—autistic disorder	8e-07	5.12e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MAPK1—autistic disorder	7.92e-07	5.07e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	7.9e-07	5.05e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—HRAS—autistic disorder	7.84e-07	5.01e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—HRAS—autistic disorder	7.77e-07	4.97e-06	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL6—autistic disorder	7.5e-07	4.8e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—HRAS—autistic disorder	7.5e-07	4.8e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—HRAS—autistic disorder	7.46e-07	4.77e-06	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL6—autistic disorder	7.43e-07	4.76e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	7.34e-07	4.7e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—HRAS—autistic disorder	7.25e-07	4.64e-06	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL6—autistic disorder	7.18e-07	4.59e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—HRAS—autistic disorder	7.14e-07	4.57e-06	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL6—autistic disorder	7.14e-07	4.57e-06	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL6—autistic disorder	6.94e-07	4.44e-06	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL6—autistic disorder	6.83e-07	4.37e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—HRAS—autistic disorder	6.58e-07	4.21e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—HRAS—autistic disorder	6.48e-07	4.14e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—HRAS—autistic disorder	6.46e-07	4.13e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—HRAS—autistic disorder	6.44e-07	4.12e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—HRAS—autistic disorder	6.42e-07	4.11e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—HRAS—autistic disorder	6.36e-07	4.07e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—HRAS—autistic disorder	6.34e-07	4.06e-06	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6—autistic disorder	6.3e-07	4.03e-06	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6—autistic disorder	6.2e-07	3.97e-06	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6—autistic disorder	6.19e-07	3.96e-06	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6—autistic disorder	6.17e-07	3.94e-06	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6—autistic disorder	6.15e-07	3.93e-06	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6—autistic disorder	6.09e-07	3.89e-06	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6—autistic disorder	6.07e-07	3.88e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HRAS—autistic disorder	5.89e-07	3.77e-06	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6—autistic disorder	5.64e-07	3.61e-06	CbGpPWpGaD
